{"name":"Entero Therapeutics","slug":"entero-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"adrulipase","genericName":"adrulipase","slug":"adrulipase","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"adrulipase","genericName":"adrulipase","slug":"adrulipase","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNQWRoMzVMVU95TmpVM2wyWXJWZmhpYTZzNlpTRXh5MkU5TV9hLTdlUHNqa3hULTR0RnZGZC1Zb3d3a2thZkFrWVNfMVI1empSVVdhLXgwOFd5Wjd5Z0JGX2Vnd19uQ0lWODFHWUw5TnlkMU9OUWlIcjhwaDFmT2xiMlZIdl9CcWstZGR0bTJpV0dzZ01PYWJ5Vm5lUHhtTWR0MmpDMzVKQXhKbGJqSGEwVjc4SzBKa195cFdaenRB?oc=5","date":"2025-11-28","type":"pipeline","source":"Stock Titan","summary":"Entero Therapeutics (NASDAQ: ENTO) to Become GridAI, Start Trading as GRDX - Stock Titan","headline":"Entero Therapeutics (NASDAQ: ENTO) to Become GridAI, Start Trading as GRDX","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxNU004YnVyVFNJX3NmLXNycTJRTGRXQ296VmFLN0ExX2pMLUdoSzFlMHhvVDg5LWFKNEFRdTRYelhHSDFEYmpUR3dSdEZGY3Ywb0dxQkUyVkpaMWw0NXMwZDFFdDVsNkxaenNuTlM0VUhBOXg5UEsxMS1XWXJ5WUpReXEzZURUTjRHSUVsbVNfSHBOZU1EZ0dkWkRUNlpVcEVoVWtKYjRrV19wWDZfVmlUS0VjZFcza1BzUzR0bldfMjN3QXQ4RFppc1VRdlJ6QVNTZDFyaThmZVJEVENYeVMzdy1pU1RyUW1aaXk5RGg1YmdRdlJZckdFRGRtVQ?oc=5","date":"2025-11-28","type":"pipeline","source":"The Clarion-Ledger","summary":"Entero Therapeutics, Inc. Announces Corporate Name Change to GridAI Technologies Corp. and New Ticker Symbol \"GRDX\" - The Clarion-Ledger","headline":"Entero Therapeutics, Inc. Announces Corporate Name Change to GridAI Technologies Corp. and New Ticker Symbol \"GRDX\" - Th","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQVHlOWW1iN0NoZHR0cEs5ZmVHazlKZWRDVnlIaldYVGM1UGxsb3dBZ2FPVHdhUThUX3Y2ZXVIbXhKcHljNG5aNzczSGJRZmlZdFNKeDlSdUFHMEp0QmQtODlrSlhYczR0VUJIdkV6OEEtVkpEcE9ZUWtHSDlyT3BTVWhsNzg1ZHZkU1gxdVp6SmFOV1BRZTZFMWZHc0hrU1FjVnBsV2s4dERGaGVHQnNiUDFFWFB1R0JYZ2VHUA?oc=5","date":"2025-10-30","type":"deal","source":"Stock Titan","summary":"Entero (NASDAQ: ENTO) acquires GRID AI, adds $50M+ grid tech and Nasdaq compliance - Stock Titan","headline":"Entero (NASDAQ: ENTO) acquires GRID AI, adds $50M+ grid tech and Nasdaq compliance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQN3VvQVMyNzY1MDdwSkk2bS1kU09TWUtXNXF0MXRaNEY5WXJmenBUdUNhMGMxYXBTUUhkdG9vWU5aWW9FcjdNeTNaVjZyaEl2bTVfcXZ4RGlMY1RKczVXQ1VTR0pqbkFxSnhRWUJ1VWtYUUJkNzBkUVpKZGZrT3cyMVFLQWhHWkR4UWdKLVlEeE1ESy1QSzJOSEptUW9qXzBwY3I4VFFFZmx1QzlJVDRSNEpQUGhuNzdlaHAwQzZIdEtiQmFmMXFxSVhzaFoza3RrMWF5V1pZVHpPVHVjeXk3Vw?oc=5","date":"2025-10-01","type":"regulatory","source":"TMX Newsfile","summary":"ENTERO THERAPEUTICS (ENTO) Acquires 100% of GRID AI, a Grid-Edge AI Platform Optimizing Next-Gen Power Demand - TMX Newsfile","headline":"ENTERO THERAPEUTICS (ENTO) Acquires 100% of GRID AI, a Grid-Edge AI Platform Optimizing Next-Gen Power Demand","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxOUlFpbDBmRk82aEV6T1hlalF3Rk1GdGJhci1xWDBiWlp4eVlHMkZOVXhidlNLZWp6RnBSMklaR2g3Z25hSEFnUllEdE5LSU9MejMyWnFyYTAtX0hXdEtaMm1DNXZkbHB6WXFBQWhkd1lWLTdHMmp2enV4XzM5SGZRWlNWNS1EMW1vMUI4QkZjeWJjeXFGUDF6bnBXekRmbVhONXpaMHMxYzJNRlNZd0RicThHVEVSVndKTHF5V1BaSTJjZ19ZYWl4emE0RGhUN3NQdkc0OTVQd1UySDBJbnRVdE5NbHNhczRJTjk3MXJkbncybW8tVjNGbFVNeTEwYkxoWDRqMG5jNVlneEFNbmc?oc=5","date":"2025-09-29","type":"pipeline","source":"scanx.trade","summary":"Entero Healthcare Solutions Reshapes Portfolio: Sells Suprabhat Pharmaceutical, Eyes Majority Stake in Ace Cardiopathy - scanx.trade","headline":"Entero Healthcare Solutions Reshapes Portfolio: Sells Suprabhat Pharmaceutical, Eyes Majority Stake in Ace Cardiopathy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxPM1VqMkd4bW15LW1RM1FTNFEzNHktNWRhM2hXWUpmMkMtRnc0dEdnaUVoYm1lMEpEQlVQSjJZN2M2ZVd5RmNVRUhmTmpvc2k5eFFaZXQycUdONVVkQ0tucGJYNXJOajY1ZE9tczVIZUp5cUZhMjFWaUpSV2ptclN4ZGl6NmVidXc1ZmU0MzYxTUVfWUZveTVzOS16YXpXaUNVS0V6TUM5dFQwT1huMjRnYnJtQWdwMjNxLTNiMUQtSW1odlNFNWREbGY0Q0JvR2ZuZ2ZQajYxazVxQ1BXdnYwamZONEJ0RkNha1M1NGF1djZlZ0NKVGhiVG50RQ?oc=5","date":"2024-11-19","type":"pipeline","source":"PR Newswire","summary":"Celiac Disease Pipeline Grows as 25+ Key Pharma Companies Join the Fight for Innovative Treatments | DelveInsight - PR Newswire","headline":"Celiac Disease Pipeline Grows as 25+ Key Pharma Companies Join the Fight for Innovative Treatments | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AJBVV95cUxQbnJWUk42Y0RDUHdUUkhKTVFuQmJMZm9fekZZWnBMZVZqY0dZQURUVTlIOFpvTlR1b0UtT1pNQVNIRFBJX3k1Y2NfSnFWV0toZ3pjTV84UTcyMUloU2NES0FocVNJRkpGQTROUGNRdzFPQUNZZXhWNFU2Xy16OFg1X3Q5TTBucXEzY0xyWlpuazFaSDF0Rm5LNERsSEtzYUJwVVhuRE9pWk8xWTBOU0hjUW94aWxsazY3SnBoQWZycG9jUVJtRkJ3OF9hWEZtUHBUcWw2aDJJVXI1Q21JWmNOaGNENjVJTmE1X1JXekVrZ0RNdWkwbElrUWZfaHNrZF9iSzFSQlFFa2RHNlhxWV90RTRvcEhhc1NDcHlOSVp0R29ZT3Z3cTdhSTBJbTh1STdYcXQxZF9JamJYYXFqZDlJb0dwWlJpdVF6dy16bXJpZVA5T3RidS1YTWc0UGZhUzJuOWk3OG03bnZEejRl?oc=5","date":"2024-11-13","type":"deal","source":"GlobeNewswire","summary":"Entero Therapeutics Announces Proposed Reverse Merger with - GlobeNewswire","headline":"Entero Therapeutics Announces Proposed Reverse Merger with","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQdDNiVjZ5azFjaGdnODFBcjRJczRHbWRtM3dFTUxCNVZqVEMxSFQzRWRtWkp6d0VFc1BtaDJzaloweVVkajE3X0RoNFRZS3h1aFZDb1dKNm1iMVgwVkF4X2dRVHFVN3VWcGo0RmF0YTlhaEViQzJ3YzhYTnVLMV9ic2JXMmRhUXpvNHlDdENzcVRhbGZjbXVEUEtmcFd5eTJSakhJQmd6RzBwMTFHUWtqMGVBb1R1UGJ2a0I0U1lGMTdoT1E?oc=5","date":"2024-08-08","type":"pipeline","source":"Fierce Biotech","summary":"Entero laying off staff, vacating office and pausing R&D as Mattress provides hard landing - Fierce Biotech","headline":"Entero laying off staff, vacating office and pausing R&D as Mattress provides hard landing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTFAzWjBzcE9KVl9GR3U0dVpCWVB5eDByYlg0TG9wTVdoWXpDZUxpWDk3WWs0dkxxRWl4V0Q3MVVpZWFzZ01NRWdNZjJ2bkpiYW1SVzJFdF8zcV9IQQ?oc=5","date":"2024-05-22","type":"pipeline","source":"MarketBeat","summary":"Entero Therapeutics (ENTO) Stock Price, News & Analysis - MarketBeat","headline":"Entero Therapeutics (ENTO) Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxObGdYZEtJTzVQUGVMS2tzQmhJSVJ0UGZiRUV3dDE3bWppdG10TkV6VGNmT0R4SjJuVHNfZlZuZlN2RkFWV2VXc3ZiSlQ1MGdhblhBR1BpeWNxUUQyWlphbXBnLWlxSTg1T2l6cHQ3REhlb1VjTWZidjVtVDNWWkNfQVlwT09MV2pBMkFLUFk3RmxNX3N6QlNXYzdUQjFXb09pempreTJxbVFjNjA?oc=5","date":"2024-05-17","type":"trial","source":"fiercepharma.com","summary":"First Wave BioPharma comes ashore with new name as it prepares for phase 3 trial - fiercepharma.com","headline":"First Wave BioPharma comes ashore with new name as it prepares for phase 3 trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQcjd5b0s5bjBlRlIzNURLZEhhN3Z5UHdEOHkzYnQ1a2tIbUVCV0hWb2EzYS03N3lTYW5EWFpJY19IcXBGOWNRS2kyTkRRUldiam15SVlYTEdwanBFUmxPWkFBZFRFQUlfbzB4SFJvQ3UyamZwbHBhT0lxTkpqYmdUWGRIWWZGSDNuOTd2c0dPbDk3RkM4NjNhSXJNa2x3X28?oc=5","date":"2024-05-16","type":"pipeline","source":"Contract Pharma","summary":"First Wave BioPharma Rebrands to Entero Therapeutics - Contract Pharma","headline":"First Wave BioPharma Rebrands to Entero Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQRXcweUpuU3BmY2phbDg0bDZGeXk1c2ZNcFZJcjl4bkh1VThsWnRfNXZuMXdYei1ndllSVHNOa3VrUExpN25RcHU2ZUs2dXlMc1ZjOURaNjVfcHhLcVBnUWJ4Y29KNDlDVE5MZkF4dmstc2x2OHpsY3lOMEJOM0lUekoyYk16UQ?oc=5","date":"2024-05-16","type":"pipeline","source":"Yahoo Finance","summary":"First Wave BioPharma Changes Name to Entero Therapeutics - Yahoo Finance","headline":"First Wave BioPharma Changes Name to Entero Therapeutics","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}